Webinar
Potomac Ventures Last Call
Join Alumni Ventures’ Matt Caspari for a final opportunity to explore and invest in Potomac Ventures before the investment window closes.
This session will provide a comprehensive update on the fund’s portfolio, recent investments, and how the team is strategically positioning the fund to capitalize on emerging opportunities. Matt will discuss key startups backed by Potomac Ventures and how the fund is targeting sectors with high-growth potential.
Whether you’re a current investor or considering joining before the deadline, this webinar will offer valuable insights into the fund’s investment strategy and long-term outlook. Don’t miss this chance to connect with the team and get your questions answered before the fund closes.
Why Attend?
- HomePortfolio Insights: Learn about the companies backed by Potomac Ventures and their growth trajectories.
- HomeSector Focus: Discover why Potomac Ventures is targeting specific industries for outsized returns.
- HomeFinal Opportunity: Understand the timeline and reasons to act before the investment window closes.
Reserve your spot today to participate in Potomac Ventures before it’s too late. Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.